We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+109.95%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$788M
AUM Growth
+$452M
Cap. Flow
+$77.8M
Cap. Flow %
9.87%
Top 10 Hldgs %
97.29%
Holding
21
New
2
Increased
8
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$45.8M
2
OPK icon
Opko Health
OPK
+$17M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$7.99M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$7.5M
5
AGEN
Agenus
AGEN
+$4.15M

Top Sells

Rank Stock Value
1
VRML
Vermillion, Inc.
VRML
+$8.18M
2
BIOL
Biolase, Inc.
BIOL
+$1.56M
3
SLNO
Soleno Therapeutics
SLNO
+$579K
4
BIIB icon
Biogen
BIIB
+$355K
5
AXDX
Accelerate Diagnostics
AXDX
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 98.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.21B
$406M 51.56%
1,816,094
+10,111
+0.6% +$1.58M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$147M 18.66%
2,011,700
+140,957
+8% +$7.5M
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
$61.7M 7.83%
406,894
-3,335
-0.8% -$329K
OPK icon
4
Opko Health
OPK
$978M
$41.1M 5.21%
12,045,886
+7,572,810
+169% +$17M
AWH
5
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$39.5M 5.01%
+685,906
New +$45.8M
AGEN
6
Agenus
AGEN
$326M
$26.4M 3.35%
342,509
+69,373
+25% +$4.15M
AMRN
7
Amarin Corp
AMRN
$297M
$15M 1.9%
108,407
+16,625
+18% +$2.29M
QDEL icon
8
CALL
QuidelOrtho
QDEL
$1.21B
$12M 1.53%
191,300
+33,900
+22% +$5.31M
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$2.24B
$9.53M 1.21%
+2,000,000
New +$7.99M
SLNO
10
DELISTED
Soleno Therapeutics
SLNO
$8.15M 1.03%
244,692
-13,350
-5% -$579K
MOTS
11
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$5.03M 0.64%
12,689
– –
ATRS
12
DELISTED
Antares Pharma, Inc.
ATRS
$4.67M 0.59%
1,699,566
+472,452
+39% +$1.32M
PACB icon
13
Pacific Biosciences
PACB
$441M
$4.55M 0.58%
1,320,359
+100,000
+8% +$340K
BHVN
14
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.49M 0.32%
63,100
-36,900
-37% -$1.96M
YMAB
15
DELISTED
Y-mAbs Therapeutics
YMAB
$1.09M 0.14%
25,212
– –
BIOL
16
DELISTED
Biolase, Inc.
BIOL
$1M 0.13%
696
-1,373
-66% -$1.56M
BIIB icon
17
Biogen
BIIB
$29.8B
$987K 0.13%
3,688
-1,180
-24% -$355K
CFRX
18
DELISTED
ContraFect Corporation
CFRX
$823K 0.1%
1,611
– –
AXDX
19
CALL
DELISTED
Accelerate Diagnostics
AXDX
$686K 0.09%
13,790
-25,050
-64% -$2.47M
AMRN
20
CALL
Amarin Corp
AMRN
$297M
– –
-17,550
Closed -$2K
VRML
21
DELISTED
Vermillion, Inc.
VRML
– –
-9,825,289
Closed -$8.18M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Oracle Investment Management held 21 positions worth $788M, up 134% from $337M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Oracle Investment Management deployed $77.8M of net new capital in Q2 2020, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was Aspira Women's Health Inc. Common Stock: 685,906 shares worth $39.5M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Biolase, Inc., an estimated $1.56M trimmed.

  • Oracle Investment Management's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 685,906 shares worth $39.5M.
  • Oracle Investment Management added most to Opko Health in Q2 2020, an estimated $17M increase.
  • Oracle Investment Management's biggest Q2 2020 reduction was Biolase, Inc., cutting an estimated $1.56M.
  • Oracle Investment Management fully exited Vermillion, Inc. in Q2 2020, selling an estimated $8.18M.
  • Oracle Investment Management's ten largest holdings make up 97% of its $788M portfolio in Q2 2020.
  • Oracle Investment Management opened 2 new positions and closed 2 in Q2 2020.
  • Oracle Investment Management's portfolio value rose 134% quarter-over-quarter to $788M.

Based on Oracle Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.